NO20072393L - P13-kinase gamma hemmere for behandling av anemi - Google Patents
P13-kinase gamma hemmere for behandling av anemiInfo
- Publication number
- NO20072393L NO20072393L NO20072393A NO20072393A NO20072393L NO 20072393 L NO20072393 L NO 20072393L NO 20072393 A NO20072393 A NO 20072393A NO 20072393 A NO20072393 A NO 20072393A NO 20072393 L NO20072393 L NO 20072393L
- Authority
- NO
- Norway
- Prior art keywords
- anemia
- treatment
- kinase
- inhibitors
- gamma inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Den foreliggende oppfinnelsen vedrører anvendelse av selektive P13-kinase ?-hemmere for fremstillingen av et medikament for behandling av lidelser på grunn av erytrocyttsvikt. Mer spesifikt angår oppfinnelsen bruken av selektive P13-kinase ?-hemmere, for eksempel substituerte azolidinonvinylkondenserte benzenderivater med formel I hvor A, X, Yl, Y2, X, N, R1 og R2 er som detaljert beskrevet i den etterfølgende beskrivelsen for behandlingen av en anemi, inklusive hemolytisk anemi, aplastisk anemi og ren rødcelleanemi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04104997 | 2004-10-12 | ||
PCT/EP2005/055156 WO2006040318A2 (en) | 2004-10-12 | 2005-10-11 | Pi3 kinase gamma inhibitors for the treatment of anaemia |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072393L true NO20072393L (no) | 2007-05-09 |
Family
ID=34929693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072393A NO20072393L (no) | 2004-10-12 | 2007-05-09 | P13-kinase gamma hemmere for behandling av anemi |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090042773A1 (no) |
EP (1) | EP1807075A2 (no) |
JP (1) | JP2008515955A (no) |
KR (1) | KR20070073857A (no) |
CN (1) | CN101056633A (no) |
AU (1) | AU2005293556A1 (no) |
BR (1) | BRPI0517416A (no) |
CA (1) | CA2580480A1 (no) |
EA (1) | EA200700848A1 (no) |
IL (1) | IL182110A0 (no) |
MX (1) | MX2007004302A (no) |
NO (1) | NO20072393L (no) |
WO (1) | WO2006040318A2 (no) |
ZA (1) | ZA200702435B (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0515627A (pt) * | 2004-09-03 | 2008-07-29 | Applied Research Systems | derivado de azolidinona de metileno de piridina, uso de derivado de azolidinona de metileno de piridina, composição farmacêutica, processo para o preparo de derivado de azolidinona de metileno de piridina e composto |
EP2046333A4 (en) * | 2006-07-24 | 2010-09-15 | Glaxosmithkline Llc | THIOZOLIDINEDIONE DERIVATIVES AS INHIBITORS OF P13-KINASE |
WO2009017822A2 (en) | 2007-08-02 | 2009-02-05 | Amgen Inc. | Pi3 kinase modulators and methods of use |
WO2009085230A1 (en) | 2007-12-19 | 2009-07-09 | Amgen Inc. | Inhibitors of pi3 kinase |
US8268834B2 (en) | 2008-03-19 | 2012-09-18 | Novartis Ag | Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme |
EP2341052A4 (en) * | 2008-09-05 | 2011-10-12 | Shionogi & Co | RING-CONDENSED MORPHOLINE DERIVATIVITY WITH PI3K-INHIBITING EFFECT |
EP2412710A4 (en) * | 2009-03-27 | 2012-08-08 | Kowa Co | CONDENSED PIPERIDINE COMPOUND AND PHARMACEUTICAL AGENT CONTAINING THE SAME |
EP2440556A1 (en) * | 2009-06-10 | 2012-04-18 | Vertex Pharmaceuticals Incorporated | Inhibitors of phosphatidylinositol 3-kinase |
UY33199A (es) * | 2010-01-26 | 2011-08-31 | Boehringer Ingelheim Int | 5-alquinil-pirimidinas. |
US8609672B2 (en) | 2010-08-27 | 2013-12-17 | University Of The Pacific | Piperazinylpyrimidine analogues as protein kinase inhibitors |
CN102584809B (zh) * | 2011-01-14 | 2014-12-24 | 湘北威尔曼制药股份有限公司 | 胺基噻唑烷酮化合物及其制备方法与在制备抗肿瘤药物中的应用 |
AU2012245344B2 (en) | 2011-04-22 | 2017-11-09 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
US8927525B2 (en) | 2011-11-04 | 2015-01-06 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
MY170922A (en) | 2011-12-22 | 2019-09-18 | Novartis Ag | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
JP6454727B2 (ja) | 2014-04-24 | 2019-01-16 | ノバルティス アーゲー | ホスファチジルイノシトール3−キナーゼ阻害薬としてのアミノピリジン誘導体 |
EA033571B1 (ru) | 2014-04-24 | 2019-11-06 | Novartis Ag | Производные пиразина в качестве ингибиторов фосфатидилинозитол 3-киназы |
KR20160141855A (ko) | 2014-04-24 | 2016-12-09 | 노파르티스 아게 | 포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피라진 유도체 |
FI3781561T3 (fi) | 2018-04-18 | 2024-06-13 | Constellation Pharmaceuticals Inc | Metyyliä muuntavien entsyymien modulaattoreita, niiden koostumuksia ja käyttöjä |
US11919912B2 (en) | 2018-05-21 | 2024-03-05 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
JPWO2022163843A1 (no) * | 2021-02-01 | 2022-08-04 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI240627B (en) * | 1996-04-26 | 2005-10-01 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
CA2493843C (en) * | 2002-07-10 | 2012-04-17 | Applied Research Systems Ars Holding N.V. | Azolidinone-vinyl fused-benzene derivatives |
ES2315566T3 (es) * | 2002-11-22 | 2009-04-01 | Smithkline Beecham Corporation | Tiazolidin-4-onas para inhibir proteinas hyak3. |
-
2005
- 2005-10-11 ZA ZA200702435A patent/ZA200702435B/en unknown
- 2005-10-11 MX MX2007004302A patent/MX2007004302A/es not_active Application Discontinuation
- 2005-10-11 CN CNA200580038804XA patent/CN101056633A/zh active Pending
- 2005-10-11 EA EA200700848A patent/EA200700848A1/ru unknown
- 2005-10-11 AU AU2005293556A patent/AU2005293556A1/en not_active Abandoned
- 2005-10-11 WO PCT/EP2005/055156 patent/WO2006040318A2/en active Application Filing
- 2005-10-11 US US11/664,969 patent/US20090042773A1/en not_active Abandoned
- 2005-10-11 EP EP05801722A patent/EP1807075A2/en not_active Withdrawn
- 2005-10-11 BR BRPI0517416-3A patent/BRPI0517416A/pt not_active IP Right Cessation
- 2005-10-11 JP JP2007536166A patent/JP2008515955A/ja active Pending
- 2005-10-11 CA CA002580480A patent/CA2580480A1/en not_active Abandoned
- 2005-10-11 KR KR1020077010007A patent/KR20070073857A/ko not_active Application Discontinuation
-
2007
- 2007-03-22 IL IL182110A patent/IL182110A0/en unknown
- 2007-05-09 NO NO20072393A patent/NO20072393L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL182110A0 (en) | 2007-07-24 |
EA200700848A1 (ru) | 2007-10-26 |
US20090042773A1 (en) | 2009-02-12 |
WO2006040318A3 (en) | 2006-08-10 |
CA2580480A1 (en) | 2006-04-20 |
EP1807075A2 (en) | 2007-07-18 |
JP2008515955A (ja) | 2008-05-15 |
AU2005293556A1 (en) | 2006-04-20 |
CN101056633A (zh) | 2007-10-17 |
WO2006040318A2 (en) | 2006-04-20 |
ZA200702435B (en) | 2008-06-25 |
BRPI0517416A (pt) | 2008-10-07 |
KR20070073857A (ko) | 2007-07-10 |
MX2007004302A (es) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072393L (no) | P13-kinase gamma hemmere for behandling av anemi | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
NO20062335L (no) | Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer | |
NO20044826L (no) | Pyrrolidinderivater | |
NO20060001L (no) | Nye P2X7-reseptorantagonister og deres anvendelse | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
NO20050828L (no) | lndol-3-svovelderivater | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20063470L (no) | Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
NO20051826L (no) | Heterosyklisk substituerte piperaziner for behandling av schizofreni | |
NO20075624L (no) | Nye histamin H3-reseptorligander og deres terapeutiske anvendelser | |
NO20071108L (no) | Nye 4-benzylidenpiperidinderivater | |
NO20054312L (no) | HIV-replikasjonsinhiberende pyrimidiner og triaziner | |
NO20075158L (no) | Nye sykliske aminer | |
NO20071593L (no) | Pyrimidinderivater | |
NO20066055L (no) | Pyridinderivater | |
NO20072689L (no) | Tetrasykliske indolderivater som antivirale midler | |
NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
NO20071504L (no) | Pyrimidinderivanter. | |
NO20051223L (no) | Oksadiazoler som modulatorer av metabotropisk glutamat reseptor-5. | |
NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
DK1807072T3 (da) | Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1 | |
NO20063355L (no) | Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |